Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

DIRS - Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, Acquisition of 90,000 shares through the exercise of 90,000 stock options under the 2011 stock option program (tranche 2; issue 2016) for employees and me

Company: Heidelberg Pharma AG Date: 2025-07-24 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

 News Details 

Directors’ Dealings | 24 July 2025 14:24

#   

Heidelberg Pharma AG: Prof. Dr. Andreas Pahl, Acquisition of 90,000 shares through the exercise of 90,000 stock options under the 2011 stock option program (tranche 2; issue 2016) for employees and members of the Management Board of Heidelberg Pharma AG.

  

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them  

  

24.07.2025 / 14:23 CET/CEST  

The issuer is solely responsible for the content of this announcement.  

  

- - -

**1\. Details of the person discharging managerial responsibilities / person closely associated**  

  

a) Name  

|     |     |
| --- | --- |
| Title: | Prof. Dr. |
| First name: | Andreas |
| Last name(s): | Pahl |

  

**2\. Reason for the notification**  

  

a) Position / status  

|     |     |
| --- | --- |
| Position: | Member of the managing body |

  

b) Initial notification  

  

**3\. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor**  

  

a) Name  

Heidelberg Pharma AG  

b) LEI  

391200E09XYBYITR1W32  

**4\. Details of the transaction(s)**  

  

a) Description of the financial instrument, type of instrument, identification code  

|     |     |
| --- | --- |
| Type: | Share |
| ISIN: | DE000A11QVV0 |

  

b) Nature of the transaction  

|     |
| --- |
| Acquisition of 90,000 shares through the exercise of 90,000 stock options under the 2011 stock option program (tranche 2; issue 2016) for employees and members of the Management Board of Heidelberg Pharma AG. |
| Transaction linked to the exercise of share option programmes |

  

c) Price(s) and volume(s)  

|     |     |
| --- | --- |
| Price(s) | Volume(s) |
| 1.89 EUR | 170,100.00 EUR |

  

d) Aggregated information  

|     |     |
| --- | --- |
| Price | Aggregated volume |
| 1.8900 EUR | 170,100.0000 EUR |

  

e) Date of the transaction  

23/07/2025; UTC+2  

f) Place of the transaction  

Outside a trading venue  

  

- - -

24.07.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.  

Archive at www.eqs-news.com  

- - -

|     |     |
| --- | --- |
| Language: | English |
| Company: | Heidelberg Pharma AG |
|     | Gregor-Mendel-Str. 22 |
|     | 68526 Ladenburg |
|     | Germany |
| Internet: | www.heidelberg-pharma.com |

  

|     |     |
| --- | --- |
|     |     |
| End of News | EQS News Service |

- - -

99844  24.07.2025 CET/CEST

![](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2174234&application_name=news&site_id=airport_aws~~~7cc68db1-74de-43c8-af69-2ae0a97efdc3)

Unlock Europe's Largest Financial Database—Free

Get instant access to over 2.8M filings from 8,970 companies across 44 markets. No cost. No hassle. Just results.

Save hours with instant data access
Trusted by leading financial institutions
Free forever—no strings attached

Or sign up with

Google Microsoft

Or log in with

Google Microsoft

This premium feature is designed for professionals. Upgrade your plan to gain immediate access and enhance your research capabilities.

Upgrade Now